Form 4: NHC Senior VP Exercises Stock Options
Insider Transaction Report
National Healthcare Corp's Senior VP of Patient Services, Vicki L Dodson, exercised stock options and sold shares to cover taxes.
Summary
- Vicki L Dodson, Senior VP Patient Services at National Healthcare Corp (NHC), exercised 3,734 stock options on March 16, 2026, at an exercise price of $53.94 per share.
- These options were granted on March 8, 2023, under the 2020 Omnibus Equity Incentive Plan.
- Following the exercise, 2,034 shares were disposed of (withheld by the company) at a price of $164.96 per share to cover the exercise price and withholding tax obligations.
- Dodson's direct beneficial ownership of Common Stock increased to 14,412.5455 shares after these transactions.
- Remaining derivative holdings include options for 8,000 shares at $94.10 (exercisable 03/05/2025, expires 03/05/2029), 9,000 shares at $90.62 (exercisable 02/24/2026, expires 02/24/2030), and 14,000 shares at $157.13 (exercisable 02/23/2027, expires 02/23/2031).
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting a standard executive compensation transaction where an insider realizes value from previously granted equity.
Positives
- The Senior VP exercised stock options, indicating a realization of value from previously granted equity incentives.
- The exercise price of $53.94 is substantially lower than the market price of $164.96 at which shares were disposed for tax purposes, reflecting a significant in-the-money value for the options.
Negatives
- A portion of the acquired shares (2,034 shares) was immediately sold back to the company to cover tax obligations and the exercise price, which represents a reduction in direct shareholding.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that routine insider transactions like option exercises and tax-related sales are common and generally do not signal significant shifts in company strategy or performance, but rather reflect standard executive compensation practices.
Key Dates
| Date | Description |
|---|---|
| 03/08/2023 | Grant date of the stock options exercised. |
| 03/08/2024 | Date exercisable for the 3,734 options exercised. |
| 03/05/2025 | Date exercisable for 8,000 options to purchase Common Stock. |
| 02/24/2026 | Date exercisable for 9,000 options to purchase Common Stock. |
| 03/16/2026 | Transaction date for the exercise of options and disposition of shares. |
| 03/18/2026 | Signature date of the reporting person on the Form 4. |
| 02/23/2027 | Date exercisable for 14,000 options to purchase Common Stock. |
| 03/08/2028 | Expiration date for the 3,734 options exercised. |
| 03/05/2029 | Expiration date for 8,000 options to purchase Common Stock. |
| 02/24/2030 | Expiration date for 9,000 options to purchase Common Stock. |
| 02/23/2031 | Expiration date for 14,000 options to purchase Common Stock. |
Recommendation
holdThis Form 4 reports a routine exercise of stock options and a subsequent sale of shares to cover taxes by a Senior VP. Such transactions are common for executives and do not typically provide a strong signal for investment action. The realization of value from options is positive for the executive but does not inherently change the company's fundamental outlook.
Keywords
NHC, National Healthcare Corp, insider trading, stock options, Form 4, executive compensation, Vicki L Dodson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.